PATENT CLAIM ANALYSIS

Application Number: 16058888
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-07
Patent Classification: ["424", "450000"]

Abstract:
The present invention relates to a method of immune activation which is effective for eliciting a non-antigen-specific immune response in a member of the bovine species. The method is particularly effective for protecting a member of the bovine species from infectious disease and treating animals inflicted with infectious disease.

Claim (Index 13):
A method for reducing clinical signs caused by Mannheimia haemolytica in cattle comprising administering to the cattle an immunomodulator composition consisting essentially of:\n a. a cationic liposome delivery vehicle; and b. an isolated bacterially-derived nucleic acid molecule that does not code for an immunogen, which is produced in  Escherichia coli,  wherein the immunomodulator composition elicits a non-antigen specific immune response.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 96.0
- Lexical Diversity: 1.54545
- Patent Class: 424.0
- Transitional Phrase Type: half
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13121566', '14633920', '15962414', '14075169', '14991003']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.722663528201594
- 35 USC 102 Novelty (BERT): 0.4980391360141595
- Combined Prediction Score: 0.7002010889828505
- Mean Citation Score: 202.762898
- Max Citation Score: 211.10802
- Similarity Product: 145.54400056207183

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test